Pharmaco - Press Releases

Date	Title	Company
06-Jul-2023	Cantourage Group SE announces partnership with Canadian grower Costa Canna	Cantourage Group SE
06-Jul-2023	Douglas GmbH: Standard & Poor’s upgrades DOUGLAS‘ outlook to stable, affirms rating	Douglas GmbH
06-Jul-2023	AEVIS VICTORIA SA – Fabrice Zumbrunnen joins the Board of Directors of Swiss Medical Network SA	AEVIS VICTORIA SA
06-Jul-2023	Gerresheimer AG: Gerresheimer continues dynamic growth in first half of 2023	Gerresheimer AG
05-Jul-2023	Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program	Cellbox Solutions
05-Jul-2023	Cantourage Group SE starts cooperation with a leading pharmaceutical wholesaler in Austria to supply the market with THC	Cantourage Group SE
05-Jul-2023	Just – Evotec Biologics awarded second contract from U.S. Department of Defense under accelerated antibodies program	Evotec SE
05-Jul-2023	Invitation to Cosmo’s Half-Year 2023 Webcast on 26 July 2023	Cosmo Pharmaceuticals N.V.
04-Jul-2023	Medacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique solution for acetabular realignment	Medacta Group SA
04-Jul-2023	STRATEC COMPLETES ACQUISITION OF NATECH PLASTICS	STRATEC SE
04-Jul-2023	DEFENCE AND VIEWPOINT WITH DENNIS QUAID JOIN FORCES TO EXPLORE BREAKTHROUGHS IN BIOTECHNOLOGY	Defence Therapeutics Inc.
30-Jun-2023	Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine	teva
30-Jun-2023	Cannovum Cannabis AG : Cultivation alliance for recreational cannabis continues to expand	Cannovum Cannabis AG
30-Jun-2023	Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions	Spexis AG
29-Jun-2023	Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	Kinarus Therapeutics Holding AG
29-Jun-2023	Cantourage Group SE sets corporate record: four new cultivation partners within a month	Cantourage Group SE
29-Jun-2023	Successful Artificial Intelligence led programme identifies multiple influenza drug targets	Poolbeg Pharma
29-Jun-2023	LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS.1	Eli Lilly and Company
29-Jun-2023	Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics	Heidelberg Pharma AG
29-Jun-2023	Mainz Biomed Secures up to $50M in New Funding	Mainz BioMed N.V.